MBX Biosciences reported total assets of $435.91M and total liabilities of $26.37M for the quarter ended Jun 2026, up 88.3% year over year. This balance sheet covers 12 quarters of results from Sep 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | 0.18M | 0.36M | 0.42M | 0.50M | 0.56M | 0.61M | 0.67M | 0.73M | 0.81M | |||
| Assets | ||||||||||||
| Current Assets | ||||||||||||
| Cash & EquivalentsCash & Equiv. | 30.52M | 132.87M | 49.35M | 29.90M | 39.78M | 223.12M | 75.29M | 45.21M | 54.12M | |||
| Receivables - OtherOther Receivables | 0.21M | 0.86M | 0.68M | 1.39M | 0.84M | 1.55M | 2.12M | 3.16M | 3.04M | |||
| Prepaid Assets | 2.79M | 4.11M | 5.14M | 3.49M | 4.28M | 5.83M | 7.83M | 8.56M | 9.28M | |||
| Current Assets | 83.47M | 281.17M | 267.29M | 244.28M | 229.19M | 397.50M | 381.54M | 448.54M | 427.86M | |||
| Non-Current Assets | ||||||||||||
| Property, Plant & Equipment (Net) | 0.44M | 1.03M | 1.08M | 1.51M | 1.73M | 2.00M | 2.73M | 3.13M | 4.66M | |||
| Other Non-Current Assets | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.38M | 0.58M | 0.62M | |||
| Non-Current Assets | 0.71M | 1.23M | 1.25M | 1.65M | 2.33M | 2.57M | 3.60M | 4.17M | 8.05M | |||
| Assets | 84.18M | 282.40M | 268.54M | 245.93M | 231.52M | 400.08M | 385.14M | 452.70M | 435.91M | |||
| Liabilities | ||||||||||||
| Current Liabilities | ||||||||||||
| Accounts Payables | 1.39M | 5.00M | 5.33M | 4.25M | 5.76M | 3.77M | 2.98M | 6.97M | 4.36M | |||
| Payables | 1.39M | 5.00M | 5.33M | 4.25M | 5.76M | 3.77M | 2.98M | 6.97M | 4.36M | |||
| Accumulated Expenses | 2.38M | 5.75M | 5.54M | 6.11M | 5.85M | 8.14M | 12.35M | 7.42M | 18.67M | |||
| Other Accumulated Expenses | 0.90M | 3.72M | 3.06M | 4.65M | 3.50M | 4.79M | 7.40M | 4.79M | 13.26M | |||
| Current Leases | 0.15M | 0.17M | 0.17M | 0.13M | 0.14M | 0.15M | 0.17M | 0.18M | 0.63M | |||
| Total Current Liabilities | 3.93M | 10.92M | 11.05M | 10.48M | 11.76M | 12.06M | 15.49M | 14.57M | 23.66M | |||
| Non-Current Liabilities | ||||||||||||
| Minority Interest | 115.86M | 152.36M | 115.86M | 115.86M | ||||||||
| Operating Leases | 0.17M | 0.04M | 0.51M | 0.47M | 0.42M | 0.38M | 2.71M | |||||
| Total Liabilities | 64.82M | 4.29M | 83.05M | 97.89M | 11.03M | 11.09M | 10.50M | 12.28M | 12.54M | 15.92M | 14.95M | 26.37M |
| Shareholder's Equity | ||||||||||||
| Common Equity | -64.82M | -72.47M | -83.05M | -97.89M | 271.37M | 257.44M | 235.42M | 219.24M | 387.54M | 369.22M | 437.76M | 409.54M |
| Liabilities and Shareholders Equity | 84.18M | 282.40M | 268.54M | 245.93M | 231.52M | 400.08M | 385.14M | 452.70M | 435.91M | |||
| Retained Earnings | -75.58M | -121.92M | -137.50M | -161.40M | -180.80M | -202.41M | -224.48M | -248.00M | -285.10M | |||
| Treasury Shares | 129.24M | 129.24M | 129.24M | 129.24M |